One company that is starting to earn a reputation as a friend to both investors and medical patients is MultiCell Technologies. Located in Woonsocket, Rhode Island, MultiCell is a clinical-stage biopharmaceutical company that is developing novel therapeutics and discovery tools to address unmet medical needs for the treatment of neurological disorders, hepatic disease and cancer. Today, MultiCell took a major step towards enhancing its future with the launch of a new interactive website.

The website was created to provide a new look and updated information about discovery technology platforms and leading drug candidates. Another attractive feature of this website is that it will provide information which will answer the common questions asked by investors and create a vertical line between the potential investor and the company.

Leading the way at MultiCell Technologies is Gerald Newmin who serves as the company’s Chairman and CEO. When asked what this new website will mean to the future of MultiCell, Newmin was quoted as saying, “The new website is designed to inform our shareholders, scientists and the public about the Company’s proprietary therapeutic pipeline which could fill critical unmet medical needs.”

To learn more about MultiCell Technologies and to see their new website, visit: http://www.multicelltech.com.

Let us hear your thoughts below: